TEVA Teva Pharmaceutical Industries Limited

NYSE
$39.19

Teva Pharmaceutical Industries Limited (TEVA) is confirmed to report earnings on November 3, 2026, before the market open. The consensus earnings estimate is $0.71 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +16.4% since its last earnings release on July 29, 2026.

Teva Pharmaceutical Industries Limited Missed Consensus Estimates, Guides In-line
Wednesday, July 29, 2026 · 7:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 3
Tuesday · 7:00 AM ET
Earnings Whisper
-
vs $0.71
Rev est $4.3B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $36.96

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Ltd develops, produces and markets generic, branded & OTC medicines. Some of its products are Copaxone, Azilect & Provigil.

Sector

Healthcare

Industry

Drugs - Generic

Held By 8 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.